ArborGen has built a compelling leadership position.

• The world’s leading supplier of improved seedlings with more than 2,000 customers, operating in the largest planted forest markets in the world: U.S., Brazil, Australia and New Zealand;
• A well established commercial business with more than 275 million tree sales per year;
• Outright ownership or access through licensing of key germplasm for all primary markets;
• An established research and discovery program that is balanced between our own internal program and world class external collaborations;
• The complete set of competencies required to commercialize our line of biotech products;
• A pipeline of products capable of significantly raising the per acre productivity of land for customers in key markets;
• A portfolio of field trials across multi-customer and geographic sites ;
• A strong intellectual property position either through our own patent protection or through license agreements;
• A track record in the regulatory arena with the first petition submitted for Freeze Tolerant Eucalyptus;
• Scale-up and commercial production capabilities;
• A dedicated effort to gain public acceptance for biotechnology;
• A world class management team with specialists in each of the key business areas.